"Medicare Part D" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A stand-alone drug plan offered by insurers and other private companies to beneficiaries that receive their Medicare Part A and/or B benefits through the Original Medicare Plan. It includes Medicare Private Fee-for-Service Plans that do not offer prescription drug coverage and Medicare Cost Plans offering Medicare prescription drug coverage. The plan was enacted as the Medicare Prescription Drug, Improvement and Modernization Act of 2003 with coverage beginning January 1, 2006.
Descriptor ID |
D054524
|
MeSH Number(s) |
N03.219.521.576.343.575.500 N03.219.521.576.343.840.938 N03.706.615.752
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Medicare Part D".
Below are MeSH descriptors whose meaning is more specific than "Medicare Part D".
This graph shows the total number of publications written about "Medicare Part D" by people in this website by year, and whether "Medicare Part D" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2015 | 1 | 0 | 1 |
2016 | 1 | 1 | 2 |
2017 | 2 | 1 | 3 |
2018 | 4 | 5 | 9 |
2019 | 4 | 1 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Medicare Part D" by people in Profiles.
-
Comparing apples with oranges: administrative expenses and finances in Medicare systems. Am J Manag Care. 2021 04 01; 27(4):e123-e129.
-
Impediments to Implementing Guideline-Directed Medical Therapies. JAMA Cardiol. 2019 08 01; 4(8):830-831.
-
Spending on World Health Organization essential medicines in Medicare Part D, 2011-15: retrospective cost analysis. BMJ. 2019 07 17; 366:l4257.
-
Prescription Drug Spending and Medication Adherence Among Medicare Beneficiaries with Heart Failure. J Manag Care Spec Pharm. 2019 Jun; 25(6):705-713.
-
Correlation of antimicrobial prescription rate and county income in medicare part D. Medicine (Baltimore). 2019 May; 98(22):e15914.
-
Pharmacy Benefit Managers: Practices, Controversies, and What Lies Ahead. Issue Brief (Commonw Fund). 2019 Mar 01; 2019:1-11.
-
The association of pre- and posthospital medication adherence in myocardial infarction patients. Am Heart J. 2019 02; 208:74-80.
-
Low Utilization of Beta-Blockers Among Medicare Beneficiaries Hospitalized for Heart Failure With Reduced Ejection Fraction. J Card Fail. 2019 May; 25(5):343-351.
-
Out-of-Pocket Costs for Infliximab and Its Biosimilar for Rheumatoid Arthritis Under Medicare Part D. JAMA. 2018 09 04; 320(9):931-933.
-
Medicare Spending on Brand-name Combination Medications vs Their Generic Constituents. JAMA. 2018 08 21; 320(7):650-656.